To include your compound in the COVID-19 Resource Center, submit it here.
INDICATION: Lung cancer; non-small cell lung cancer (NSCLC)
Cell culture and mouse studies suggest inhibiting Chk1 alone or in combination with Gemzar gemcitabine could help treat
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury